XML 24 R17.htm IDEA: XBRL DOCUMENT
v3.24.3

Net Loss Per Share | 9 Months Ended
--- | ---
Sep. 30, 2024
Earnings Per Share [Abstract] |
Net loss per share | 9. Net loss per share The following table summarizes the computation of basic and diluted net loss per share of the Company (in thousands except share and per share amounts):
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |  |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |  |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  | $ | (26,430 | ) |  | $ | (24,542 | ) |  | $ | (78,499 | ) |  | $ | (77,741 | ) |
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted-average number of common shares, basic and diluted |  |  | 56,341,074 |  |  |  | 44,266,017 |  |  |  | 52,991,015 |  |  |  | 43,669,987 |  |
Net loss per share, basic and diluted |  | $ | (0.47 | ) |  | $ | (0.55 | ) |  | $ | (1.48 | ) |  | $ | (1.78 | ) |
The Company has included the outstanding pre-funded warrants from the April 2024 offering in the number of total outstanding shares used for the computation of basic and diluted net loss per share for the period ending September 30, 2024, since they have a de minimis exercise price. The Company’s potential dilutive securities, which include common stock options, RSUs, PSUs, and ESPP purchase rights, have been excluded from the computation of diluted net loss per share as the effect would be anti-dilutive. Therefore, the weighted average number of shares of the Company’s common stock outstanding, including warrants, used to calculate both basic and diluted net loss per share is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at period end, from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:
|  | September 30, |
|  | 2024 |  |  | 2023 |
Outstanding options to purchase common stock |  |  | 8,683,588 |  |  |  | 9,467,860 |
Restricted stock units |  |  | 2,341,683 |  |  |  | 779,700 |
Total |  |  | 11,025,271 |  |  |  | 10,247,560 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration